查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1751238

远距医疗市场规模、份额、趋势分析报告：按类型、地区、细分市场、预测，2025 年至 2030 年

Telecare Market Size, Share & Trends Analysis Report By Type (Activity Monitoring, Remote Medication Management), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

远距医疗市场的成长与趋势：

根据 Grand View Research, Inc. 的最新报告，全球远距医疗市场规模预计到 2030 年将达到 63.4 亿美元，2025 年至 2030 年的复合年增长率为 4.79%。

远距医疗主要服务于社会弱势群体和老年人，使他们能够在紧急情况下立即联繫到相关人员寻求协助。此外，从电话到线上虚拟问诊，新技术的不断发展塑造了现代医疗服务的面貌。因此，技术进步在推动市场成长方面发挥关键作用。穿戴式装置、远端监控系统和远端医疗平台等创新技术正在透过实现即时健康监测、虚拟问诊和远端病患管理，彻底改变医疗保健服务。例如，2023年6月，Telecare推出了澳洲独立的电子处方笺平台RxPad。

这项创新解决方案由临床医生设计，服务于临床医生，旨在取代传统的纸处方笺。 RxPad 彻底改变了医疗服务方式，改善了病患体验，增强了医生的能力，使所有相关人员的咨询更加有效率和愉快。这项创新设备提供了市场上最先进的功能。此外，日益增长的老化人口是市场扩张的主要驱动力。随着老龄化人口的增长，对医疗服务的需求也日益增长，尤其是慢性病管理和老年护理。 Telecare 透过为老年人提供持续的监控和支持，为满足这项需求提供了可行的解决方案。这使老年患者能够在获得及时医疗护理的同时过着独立的生活。

这些人口结构的变化为远距照护解决方案创造了一个巨大的市场，这些解决方案可以满足老年人的独特需求，并促进老龄化社会的安全、健康和福祉。此外，慢性病的日益普及和对个人化医疗解决方案日益增长的需求，正在推动远距照护技术的应用。糖尿病、高血压和心臟病等慢性疾病需要持续的监测和管理，远端监控解决方案可以有效地促进这一进程。远距照护可以进行预防性疾病管理、併发症的早期发现和及时干预，从长远来看可以改善患者的治疗效果并降低医疗成本。随着医疗保健相关人员意识到远端监控和护理管理解决方案在提供可访问、经济高效和以患者为中心的医疗服务方面的变革潜力，预计市场将继续增长。

远距医疗市场报告重点

  • 到 2024 年，远距药物管理领域将以 50.97% 的最大收益占有率引领市场。这一增长可以归因于多种因素，包括人口老化、慢性病患病率上升、老年人远距照护应用程式的开发以及技术进步。
  • 由于技术进步以及对改善医疗保健管道和结果的需求不断增加，预计活动监测部门在预测期内将以显着的复合年增长率成长。
  • 到 2024 年，北美将以 49.13% 的最大收益占有率占据远距医疗市场的主导地位，这归因于智慧型手机和网路普及率高、个人保持身体健康意识增强以及远距医疗服务的利用等多种因素。

目录

第一章调查方法与范围

第二章执行摘要

第三章远距医疗市场变数、趋势和范围

  • 市场展望
    • 母市场展望
    • 补贴市场前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 远距医疗：市场分析工具
    • 产业分析-波特五力分析
    • PESTLE分析
  • 远距医疗市场：医疗系统的成果与机会
  • 远距医疗市场新兴企业和成熟公司的分析
  • 各国监管状况

4. 2018 年至 2030 年按类型分類的远距医疗市场細項分析

  • 定义和范围
  • 2024 年及 2030 年各类型市场占有率分析
  • 细分仪表板
  • 2018-2030 年全球远距医疗市场（按类型）
  • 活动监控
  • 远端药物管理

5. 2018 年至 2030 年按地区分類的远距医疗市场細項分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 区域市场概况
  • 2024 年及 2030 年各地区远距医疗市场占有率
  • 北美洲
    • 2018-2030年北美远距医疗市场
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 欧洲远距护理市场，2018-2030
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 亚太远距护理市场，2018-2030
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 拉丁美洲远距护理市场，2018-2030
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 2018-2030年中东和非洲远距医疗市场
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第六章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司分类
  • Company Position Analysis
  • Company Evaluation Metrix
  • 公司简介
    • Teladoc Health, Inc.
    • Abbott Laboratories
    • Johnson and Johnson
    • AstraZeneca PLC
    • F. Hoffmann-La Roche Ltd.
    • Novartis AG
    • NeoRehab
    • Bristol-Myers Squibb Company
    • GlaxoSmithKline plc
    • Merck and Co., Inc.
    • Pfizer, Inc.
    • Sanofi
    • Samsung Electronics Co. Ltd
    • Qualcomm Technologies, Inc.
    • Orange
    • Google（Alphabet）, Inc
    • Allscripts
    • Apple, Inc.
    • AT&T
    • Airstrip Technologies, Inc
Product Code: GVR-4-68039-915-1

Telecare Market Growth & Trends:

The global telecare market size is estimated to reach USD 6.34 billion by 2030, registering a CAGR of 4.79% from 2025 to 2030, according to a new report by Grand View Research, Inc. Telecare provides services mainly to vulnerable and elderly individuals for immediate contact with someone for help in case of any emergency. In addition, the increasing development of new technology, from telephones to online virtual visits, has shaped the face of modern healthcare services. Thus, technological advancements have played a crucial role in driving the market growth. Innovations, such as wearable devices, remote monitoring systems, and telemedicine platforms, have revolutionized healthcare delivery by enabling real-time health monitoring, virtual consultations, and remote patient management. For instance, in June 2023, Telecare introduced RxPad, Australia's standalone platform for electronic prescriptions.

Designed by clinicians for clinicians, this innovative solution aims to replace traditional paper prescriptions. RxPad is poised to revolutionize healthcare delivery, improving patient experiences and empowering doctors, making consultations more efficient and enjoyable for everyone involved. This innovative device offers the most advanced features in the market. Moreover, the growing aging population is a significant factor propelling market expansion. With the growing aging population, the demand for healthcare services increases, particularly for chronic disease management and elderly care. Telecare offers a viable solution to meet these demands by providing continuous monitoring and support for older adults. It enables elderly patients to live independently while ensuring they receive timely medical attention.

This demographic shift is creating a substantial market for telecare solutions that cater to the specific needs of older individuals, promoting safety, health, and well-being in an aging society. Furthermore, the increasing prevalence of chronic diseases and rising demand for personalized healthcare solutions have propelled the adoption of telecare technologies. Chronic conditions, such as diabetes, hypertension, and heart disease, require continuous monitoring and management, which can be effectively facilitated through remote monitoring solutions. Telecare enables proactive disease management, early detection of complications, and timely interventions, leading to improved patient outcomes and reduced healthcare costs in the long run. The market is poised for continued growth as healthcare stakeholders recognize the transformative potential of remote monitoring and care management solutions in delivering accessible, cost-effective, and patient-centered healthcare services.

Telecare Market Report Highlights:

  • The remote medication management segment led the market with the largest revenue share of 50.97% in 2024, attributed to several factors, including the aging population, increased prevalence of chronic diseases, development of elderly telecare apps and technological advancements.
  • The activity monitoring segment is anticipated to grow at the significant CAGR over the forecast period, owing to technological advancements and the increasing demand for improved healthcare access and outcomes.
  • North America dominated the telecare market with the largest revenue share of 49.13% in 2024, attributed to several factors such as the high penetration of smartphones and the internet, growing awareness among individuals to maintain physical health and the use of remote healthcare services.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment scope
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Telecare Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Aging population and elderly care needs for telecare
      • 3.2.1.2. Technological improvements in AI and ML
      • 3.2.1.3. Advances in wearable health technology
      • 3.2.1.4. Growing shift to home healthcare services
      • 3.2.1.5. Increased focus on chronic disease management
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Privacy and security concerns over patient data
      • 3.2.2.2. Complexity of regulatory compliance
      • 3.2.2.3. Lack of standardization across platforms
      • 3.2.2.4. Limited insurance reimbursement for telecare services
    • 3.2.3. Market opportunity analysis
      • 3.2.3.1. Leveraging ai, big data, and predictive analytics
      • 3.2.3.2. Collaborations with healthcare providers and insurers
      • 3.2.3.3. Increased focus on mental health and remote counseling
    • 3.2.4. Market challenges analysis
      • 3.2.4.1. Connectivity and infrastructure gaps in rural areas
      • 3.2.4.2. Resistance from healthcare providers and traditional systems
  • 3.3. Telecare: Market Analysis Tools
    • 3.3.1. Industry analysis - Porter's
    • 3.3.2. PESTLE analysis
  • 3.4. Telecare Market: Accomplishments and Opportunities Across the Health System Sectors
  • 3.5. Analysis on Start-ups and Established Companies in Telecare Market
  • 3.6. Regulatory Landscape, By Country
    • 3.6.1. Regulatory overview
    • 3.6.2. Health data privacy and security laws
    • 3.6.3. Telemedicine licensing and reimbursement policies
    • 3.6.4. Government initiatives and support
    • 3.6.5. Emerging trends in regulatory compliance
  • 3.7. Value Chain Analysis
    • 3.7.1. Telecare value chain overview
    • 3.7.2. Key stakeholders and their roles
    • 3.7.3. Technology providers and platforms
    • 3.7.4. Service delivery and interoperability
    • 3.7.5. Distribution and supply chain management
    • 3.7.6. Revenue streams and business models
    • 3.7.7. Challenges in the value chain
  • 3.8. Technology Landscape
    • 3.8.1. Technological advancements driving telecare
    • 3.8.2. Telecare software and applications
    • 3.8.3. Data analytics and artificial intelligence
    • 3.8.4. Wearable devices and IoT integration
    • 3.8.5. Telecommunication infrastructure
  • 3.9. Case Study Analysis
  • 3.10. Funding/Investment Trends Scenario
    • 3.10.1. Venture capital (VC) deal activity
    • 3.10.2. Top 10 digital health VC deals in 2024
    • 3.10.3. Annual equity funding & deals
    • 3.10.4. Quarterly equity funding & deals
    • 3.10.5. Quarter funding & deals by global region
    • 3.10.6. Percent of quarterly deals by global region
    • 3.10.7. Percent of quarterly deals by investor group
    • 3.10.8. Annual average & median deal size
    • 3.10.9. Annual median deal size by global region
    • 3.10.10. Annual median deal size by investor group
    • 3.10.11. Annual mega-round funding & deals
    • 3.10.12. Quarterly funding & deals from mega-rounds (deals worth usd 100 million+)
    • 3.10.13. Quarter mega-round funding & deals by global region
    • 3.10.14. Quarterly mega-round deals by global region
    • 3.10.15. Quarterly mega-rounds as percentage of funding
    • 3.10.16. Quarter top equity deals
    • 3.10.17. Annual percentage of deals by deal stage
    • 3.10.18. Quarter regional deal shares by deal stage
    • 3.10.19. Annual median funding by deal stage
    • 3.10.20. Quarter top seed/angel deals
    • 3.10.21. Quarter top series A deals
    • 3.10.22. Quarter top series B deals
    • 3.10.23. Quarter top series C deals
    • 3.10.24. Quarter top series D deals
    • 3.10.25. Quarter top series E+ deals
  • 3.11. Unicorn Funding Trends in Digital Health
    • 3.11.1. Quarterly new & total unicorns (private companies valued at USD 1 billion+)
    • 3.11.2. Quarter new & total unicorns by global region
    • 3.11.3. Quarterly new unicorns by global region
    • 3.11.4. Quarter top unicorns by valuation
  • 3.12. Exit Trends in Digital Health Market
    • 3.12.1. Annual exits
    • 3.12.2. Quarterly exits
    • 3.12.3. Percent of quarterly exits by global region
    • 3.12.4. Quarter top M&A exits
    • 3.12.5. Quarter top IPOs
  • 3.13. Key Investors Analysis in the Digital Health Landscape
    • 3.13.1. Quarter top investors by company count
    • 3.13.2. Quarter top VCs by company count
    • 3.13.3. Quarter top corporate VCs (CVCs) by company count
  • 3.14. Key Investment Geographic Trends in Digital Health Market
    • 3.14.1. U.S. Trends
      • 3.14.1.1. Annual funding & deals
      • 3.14.1.2. Quarterly funding & deals
      • 3.14.1.3. Annual percentage of deals by deal stage
      • 3.14.1.4. Quarter top equity deals
      • 3.14.1.5. Annual exits
      • 3.14.1.6. Quarterly exists
      • 3.14.1.7. Quarter top investors by company count
    • 3.14.2. Asia Trends
      • 3.14.2.1. Annual funding & deals
      • 3.14.2.2. Quarterly funding & deals
      • 3.14.2.3. Annual percentage of deals by deal stage
      • 3.14.2.4. Quarter top equity deals
      • 3.14.2.5. Annual exits
      • 3.14.2.6. Quarterly exists
      • 3.14.2.7. Quarter top investors by company count
    • 3.14.3. China
    • 3.14.4. Japan
    • 3.14.5. Europe Trends
      • 3.14.5.1. Annual funding & deals
      • 3.14.5.2. Quarterly funding & deals
      • 3.14.5.3. Annual percentage of deals by deal stage
      • 3.14.5.4. Quarter top equity deals
      • 3.14.5.5. Annual exits
      • 3.14.5.6. Quarterly exists
      • 3.14.5.7. Quarter top investors by company count
    • 3.14.6. UK

Chapter 4. Telecare Market Segment Analysis, By Type, 2018-2030 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Type Market Share Analysis, 2024 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Telecare Market, by Type, 2018 to 2030
  • 4.5. Activity Monitoring
    • 4.5.1. Activity Monitoring Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Remote Medication Management
    • 4.6.1. Remote Medication Management Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Telecare Market Segment Analysis, By Region, 2018- 2030 (USD Million)

  • 5.1. Regional Market Share Analysis, 2024 & 2030
  • 5.2. Regional Market Dashboard
  • 5.3. Regional Market Snapshot
  • 5.4. Telecare Market Share by Region, 2024 & 2030:
  • 5.5. North America
    • 5.5.1. North America telecare market, 2018 - 2030 (USD Million)
    • 5.5.2. U.S.
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Regulatory Scenario
      • 5.5.2.3. Competitive Scenario
      • 5.5.2.4. U.S. telecare market, 2018 - 2030 (USD Million)
    • 5.5.3. Canada
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Regulatory Scenario
      • 5.5.3.3. Competitive Scenario
      • 5.5.3.4. Canada telecare market, 2018 - 2030 (USD Million)
    • 5.5.4. Mexico
      • 5.5.4.1. Key Country Dynamics
      • 5.5.4.2. Regulatory Scenario
      • 5.5.4.3. Competitive Scenario
      • 5.5.4.4. Mexico telecare market, 2018 - 2030 (USD Million)
  • 5.6. Europe
    • 5.6.1. Europe telecare market, 2018 - 2030 (USD Million)
    • 5.6.2. UK
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Regulatory Scenario
      • 5.6.2.3. Competitive Scenario
      • 5.6.2.4. UK telecare market, 2018 - 2030 (USD Million)
    • 5.6.3. Germany
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Regulatory Scenario
      • 5.6.3.3. Competitive Scenario
      • 5.6.3.4. Germany telecare market, 2018 - 2030 (USD Million)
    • 5.6.4. France
      • 5.6.4.1. Key Country Dynamics
      • 5.6.4.2. Regulatory Scenario
      • 5.6.4.3. Competitive Scenario
      • 5.6.4.4. France telecare market, 2018 - 2030 (USD Million)
    • 5.6.5. Italy
      • 5.6.5.1. Key Country Dynamics
      • 5.6.5.2. Regulatory Scenario
      • 5.6.5.3. Competitive Scenario
      • 5.6.5.4. Italy telecare market, 2018 - 2030 (USD Million)
    • 5.6.6. Spain
      • 5.6.6.1. Key Country Dynamics
      • 5.6.6.2. Regulatory Scenario
      • 5.6.6.3. Competitive Scenario
      • 5.6.6.4. Spain telecare market, 2018 - 2030 (USD Million)
    • 5.6.7. Norway
      • 5.6.7.1. Key Country Dynamics
      • 5.6.7.2. Regulatory Scenario
      • 5.6.7.3. Competitive Scenario
      • 5.6.7.4. Norway telecare market, 2018 - 2030 (USD Million)
    • 5.6.8. Sweden
      • 5.6.8.1. Key Country Dynamics
      • 5.6.8.2. Regulatory Scenario
      • 5.6.8.3. Competitive Scenario
      • 5.6.8.4. Sweden telecare market, 2018 - 2030 (USD Million)
    • 5.6.9. Denmark
      • 5.6.9.1. Key Country Dynamics
      • 5.6.9.2. Regulatory Scenario
      • 5.6.9.3. Competitive Scenario
      • 5.6.9.4. Denmark telecare market, 2018 - 2030 (USD Million)
  • 5.7. Asia Pacific
    • 5.7.1. Asia Pacific telecare market, 2018 - 2030 (USD Million)
    • 5.7.2. Japan
      • 5.7.2.1. Key Country Dynamics
      • 5.7.2.2. Regulatory Scenario
      • 5.7.2.3. Competitive Scenario
      • 5.7.2.4. Japan telecare market, 2018 - 2030 (USD Million)
    • 5.7.3. China
      • 5.7.3.1. Key Country Dynamics
      • 5.7.3.2. Regulatory Scenario
      • 5.7.3.3. Competitive Scenario
      • 5.7.3.4. China telecare market, 2018 - 2030 (USD Million)
    • 5.7.4. India
      • 5.7.4.1. Key Country Dynamics
      • 5.7.4.2. Regulatory Scenario
      • 5.7.4.3. Competitive Scenario
      • 5.7.4.4. India telecare market, 2018 - 2030 (USD Million)
    • 5.7.5. Australia
      • 5.7.5.1. Key Country Dynamics
      • 5.7.5.2. Regulatory Scenario
      • 5.7.5.3. Competitive Scenario
      • 5.7.5.4. Australia telecare market, 2018 - 2030 (USD Million)
    • 5.7.6. South Korea
      • 5.7.6.1. Key Country Dynamics
      • 5.7.6.2. Regulatory Scenario
      • 5.7.6.3. Competitive Scenario
      • 5.7.6.4. South Korea telecare market, 2018 - 2030 (USD Million)
    • 5.7.7. Thailand
      • 5.7.7.1. Key Country Dynamics
      • 5.7.7.2. Regulatory Scenario
      • 5.7.7.3. Competitive Scenario
      • 5.7.7.4. Thailand telecare market, 2018 - 2030 (USD Million)
  • 5.8. Latin America
    • 5.8.1. Latin America telecare market, 2018 - 2030 (USD Million)
    • 5.8.2. Brazil
      • 5.8.2.1. Key Country Dynamics
      • 5.8.2.2. Regulatory Scenario
      • 5.8.2.3. Competitive Scenario
      • 5.8.2.4. Brazil telecare market, 2018 - 2030 (USD Million)
    • 5.8.3. Argentina
      • 5.8.3.1. Key Country Dynamics
      • 5.8.3.2. Regulatory Scenario
      • 5.8.3.3. Competitive Scenario
      • 5.8.3.4. Argentina telecare market, 2018 - 2030 (USD Million)
  • 5.9. MEA
    • 5.9.1. MEA telecare market, 2018 - 2030 (USD Million)
    • 5.9.2. South Africa
      • 5.9.2.1. Key Country Dynamics
      • 5.9.2.2. Regulatory Scenario
      • 5.9.2.3. Competitive Scenario
      • 5.9.2.4. South Africa telecare market, 2018 - 2030 (USD Million)
    • 5.9.3. Saudi Arabia
      • 5.9.3.1. Key Country Dynamics
      • 5.9.3.2. Regulatory Scenario
      • 5.9.3.3. Competitive Scenario
      • 5.9.3.4. Saudi Arabia telecare market, 2018 - 2030 (USD Million)
    • 5.9.4. UAE
      • 5.9.4.1. Key Country Dynamics
      • 5.9.4.2. Regulatory Scenario
      • 5.9.4.3. Competitive Scenario
      • 5.9.4.4. UAE telecare market, 2018 - 2030 (USD Million)
    • 5.9.5. Kuwait
      • 5.9.5.1. Key Country Dynamics
      • 5.9.5.2. Regulatory Scenario
      • 5.9.5.3. Competitive Scenario
      • 5.9.5.4. Kuwait telecare market, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company Categorization
  • 6.3. Company Position Analysis
  • 6.4. Company Evaluation Metrix
  • 6.5. Company Profiles
    • 6.5.1. Teladoc Health, Inc.
      • 6.5.1.1. Company overview
      • 6.5.1.2. Financial performance
      • 6.5.1.3. Product benchmarking
      • 6.5.1.4. Strategic initiatives
    • 6.5.2. Abbott Laboratories
      • 6.5.2.1. Company overview
      • 6.5.2.2. Financial performance
      • 6.5.2.3. Product benchmarking
      • 6.5.2.4. Strategic initiatives
    • 6.5.3. Johnson and Johnson
      • 6.5.3.1. Company overview
      • 6.5.3.2. Financial performance
      • 6.5.3.3. Product benchmarking
      • 6.5.3.4. Strategic initiatives
    • 6.5.4. AstraZeneca PLC
      • 6.5.4.1. Company overview
      • 6.5.4.2. Financial performance
      • 6.5.4.3. Product benchmarking
      • 6.5.4.4. Strategic initiatives
    • 6.5.5. F. Hoffmann-La Roche Ltd.
      • 6.5.5.1. Company overview
      • 6.5.5.2. Financial performance
      • 6.5.5.3. Product benchmarking
      • 6.5.5.4. Strategic initiatives
    • 6.5.6. Novartis AG
      • 6.5.6.1. Company overview
      • 6.5.6.2. Financial performance
      • 6.5.6.3. Product benchmarking
      • 6.5.6.4. Strategic initiatives
    • 6.5.7. NeoRehab
      • 6.5.7.1. Company overview
      • 6.5.7.2. Financial performance
      • 6.5.7.3. Product benchmarking
      • 6.5.7.4. Strategic initiatives
    • 6.5.8. Bristol-Myers Squibb Company
      • 6.5.8.1. Company overview
      • 6.5.8.2. Financial performance
      • 6.5.8.3. Product benchmarking
      • 6.5.8.4. Strategic initiatives
    • 6.5.9. GlaxoSmithKline plc
      • 6.5.9.1. Company overview
      • 6.5.9.2. Financial performance
      • 6.5.9.3. Product benchmarking
      • 6.5.9.4. Strategic initiatives
    • 6.5.10. Merck and Co., Inc.
      • 6.5.10.1. Company overview
      • 6.5.10.2. Financial performance
      • 6.5.10.3. Product benchmarking
      • 6.5.10.4. Strategic initiatives
    • 6.5.11. Pfizer, Inc.
      • 6.5.11.1. Company overview
      • 6.5.11.2. Financial performance
      • 6.5.11.3. Product benchmarking
      • 6.5.11.4. Strategic initiatives
    • 6.5.12. Sanofi
      • 6.5.12.1. Company overview
      • 6.5.12.2. Financial performance
      • 6.5.12.3. Product benchmarking
      • 6.5.12.4. Strategic initiatives
    • 6.5.13. Samsung Electronics Co. Ltd
      • 6.5.13.1. Company overview
      • 6.5.13.2. Financial performance
      • 6.5.13.3. Product benchmarking
      • 6.5.13.4. Strategic initiatives
    • 6.5.14. Qualcomm Technologies, Inc.
      • 6.5.14.1. Company overview
      • 6.5.14.2. Financial performance
      • 6.5.14.3. Product benchmarking
      • 6.5.14.4. Strategic initiatives
    • 6.5.15. Orange
      • 6.5.15.1. Company overview
      • 6.5.15.2. Financial performance
      • 6.5.15.3. Product benchmarking
      • 6.5.15.4. Strategic initiatives
    • 6.5.16. Google (Alphabet), Inc
      • 6.5.16.1. Company overview
      • 6.5.16.2. Financial performance
      • 6.5.16.3. Product benchmarking
      • 6.5.16.4. Strategic initiatives
    • 6.5.17. Allscripts
      • 6.5.17.1. Company overview
      • 6.5.17.2. Financial performance
      • 6.5.17.3. Product benchmarking
      • 6.5.17.4. Strategic initiatives
    • 6.5.18. Apple, Inc.
      • 6.5.18.1. Company overview
      • 6.5.18.2. Financial performance
      • 6.5.18.3. Product benchmarking
      • 6.5.18.4. Strategic initiatives
    • 6.5.19. AT&T
      • 6.5.19.1. Company overview
      • 6.5.19.2. Financial performance
      • 6.5.19.3. Product benchmarking
      • 6.5.19.4. Strategic initiatives
    • 6.5.20. Airstrip Technologies, Inc
      • 6.5.20.1. Company overview
      • 6.5.20.2. Financial performance
      • 6.5.20.3. Product benchmarking
      • 6.5.20.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global telecare market, by type, 2018 - 2030 (USD Million)
  • Table 4 North America telecare market, by country, 2018 - 2030 (USD Million)
  • Table 5 North America telecare market, by type, 2018 - 2030 (USD Million)
  • Table 6 U.S. telecare market, by type, 2018 - 2030 (USD Million)
  • Table 7 Canada telecare market, by type, 2018 - 2030 (USD Million)
  • Table 8 Mexico telecare market, by type, 2018 - 2030 (USD Million)
  • Table 9 Europe telecare market, by country, 2018 - 2030 (USD Million)
  • Table 10 Europe telecare market, by type, 2018 - 2030 (USD Million)
  • Table 11 UK telecare market, by type, 2018 - 2030 (USD Million)
  • Table 12 Germany telecare market, by type, 2018 - 2030 (USD Million)
  • Table 13 France telecare market, by type, 2018 - 2030 (USD Million)
  • Table 14 Italy telecare market, by type, 2018 - 2030 (USD Million)
  • Table 15 Spain telecare market, by type, 2018 - 2030 (USD Million)
  • Table 16 Norway telecare market, by type, 2018 - 2030 (USD Million)
  • Table 17 Denmark telecare market, by type, 2018 - 2030 (USD Million)
  • Table 18 Sweden telecare market, by type, 2018 - 2030 (USD Million)
  • Table 19 Asia Pacific telecare market, by country, 2018 - 2030 (USD Million)
  • Table 20 Asia Pacific telecare market, by type, 2018 - 2030 (USD Million)
  • Table 21 Japan telecare market, by type, 2018 - 2030 (USD Million)
  • Table 22 China telecare market, by type, 2018 - 2030 (USD Million)
  • Table 23 India telecare market, by type, 2018 - 2030 (USD Million)
  • Table 24 Australia telecare market, by type, 2018 - 2030 (USD Million)
  • Table 25 South Korea telecare market, by type, 2018 - 2030 (USD Million)
  • Table 26 Thailand telecare market, by type, 2018 - 2030 (USD Million)
  • Table 27 Latin America telecare market, by country, 2018 - 2030 (USD Million)
  • Table 28 Latin America telecare market, by type, 2018 - 2030 (USD Million)
  • Table 29 Brazil telecare market, by type, 2018 - 2030 (USD Million)
  • Table 30 Argentina telecare market, by type, 2018 - 2030 (USD Million)
  • Table 31 Middle East & Africa telecare market, by country, 2018 - 2030 (USD Million)
  • Table 32 Middle East & Africa telecare market, by type, 2018 - 2030 (USD Million)
  • Table 33 South Africa telecare market, by type, 2018 - 2030 (USD Million)
  • Table 34 Saudi Arabia telecare market, by type, 2018 - 2030 (USD Million)
  • Table 35 UAE telecare market, by type, 2018 - 2030 (USD Million)
  • Table 36 Kuwait telecare market, by type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Telecare market: outlook
  • Fig. 8 Telecare competitive insights
  • Fig. 9 Ancillary market outlook
  • Fig. 10 Telecare market driver impact
  • Fig. 11 Telecare market restraint impact
  • Fig. 12 Porter's Analysis
  • Fig. 13 PESTLE Analysis
  • Fig. 14 Telecare market: Type movement analysis
  • Fig. 15 Telecare market: Type outlook and key takeaways
  • Fig. 16 Activity Monitoring market estimates and forecast, 2018 - 2030
  • Fig. 17 Remote Medication Management market estimates and forecast, 2018 - 2030
  • Fig. 18 Global telecare market: Regional movement analysis
  • Fig. 19 Global telecare market: Regional outlook and key takeaways
  • Fig. 20 North America telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Key country dynamics
  • Fig. 22 U.S. telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Key country dynamics
  • Fig. 24 Canada telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Key country dynamics
  • Fig. 26 Mexico telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Europe telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Key country dynamics
  • Fig. 29 UK telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Key country dynamics
  • Fig. 31 Germany telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Key country dynamics
  • Fig. 33 Spain telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Key country dynamics
  • Fig. 35 France telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Key country dynamics
  • Fig. 37 Italy telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Key country dynamics
  • Fig. 39 Norway telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Key country dynamics
  • Fig. 41 Denmark telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Key country dynamics
  • Fig. 43 Sweden telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Asia Pacific telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 Japan telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 China telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 India telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Australia telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 South Korea telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Thailand telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Latin America telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Brazil telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Argentina telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 MEA telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 South Africa telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Saudi Arabia telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 UAE telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Kuwait telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Key company categorization
  • Fig. 72 Heat map analysis, 2024